Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes

YARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) — Today, the MDS Foundation announced the development of a new prognostic scoring system, the IPSS-Molecular, that will significantly improve risk stratification upon diagnosis to better inform the way treatment plans are built for patients with Myelodysplastic Syndromes. “By considering each patient’s genetic make up in the IPSS-M […]